drugset / Trial / NCT06169085
Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to assess the safety, tolerability and PK of Leritrelvir in elder participants
Timeline
- Start
- 2023-08-24
- Primary completion
- 2023-09-20
- Completion
- 2023-10-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leritrelvir | Unknown | 400 mg | Oral |
Indications
No indication recorded.